News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Advancing molecular glue technology – Asian Fund for Cancer Research
Asian Fund for Cancer Research/LinkedIn
Dec 15, 2024, 08:27

Advancing molecular glue technology – Asian Fund for Cancer Research

Asian Fund for Cancer Research posted the following on LinkedIn:

“Thanks to the long-term support of AFCR’s loyal donors, AFCR-funded scientists have made impressive progress in the fight against cancer.

Outstanding scientific research achievements in 2024 include: the first molecular glue degradation agent. Dr. Zou Lihui researched a new class of small molecule drugs developed through a molecular glue-based targeted protein degradation platform.

The proprietary platform has curated a unique and expanding library of molecular glue compounds, enabling the targeting of previously undruggable targets.

Donate to support cancer research.
Learn more.”

AIM-HI Accelerator Fund Asian Fund for Cancer Research cancer cancer innovation Cancer research Degron Therapeutics molecular glue compounds OncoDaily Oncology oncology advancements targeted therapy undruggable targets Zou Lihui
Special Coverage
Blog
Dec 15, 2024, 08:27
Advancing molecular glue technology - Asian Fund for Cancer Research
Blog
Dec 15, 2024, 08:17
Shaibu Issa: Fighting for better hepatitis care globally
Blog
Dec 15, 2024, 08:12
Empowering community health workers - The Global Fund
Blog
Dec 15, 2024, 08:06
Erika Hamilton: Advancing breast cancer care at SABCS
Celebrities
Dec 15, 2024, 08:02
Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle
Blog
Dec 15, 2024, 06:43
Ruben Mesa: Celebrating molecular and cellular oncology progress
Blog
Dec 15, 2024, 06:15
Abeid M. Athman Omar: Improving cancer management in Nairobi
Blog
Dec 15, 2024, 05:43
Managing menopause after breast cancer - MASCC
Blog
Dec 15, 2024, 05:29
Updated OlympiA Phase 3 trial results in BRCA2 Breast Cancer - Dana-Farber’s Breast Oncology Center
Insight
Dec 15, 2024, 03:45
Elisa Agostinetto: San Antonio Breast Cancer Symposium is my favourite congress of the year
Insight
Dec 15, 2024, 03:43
Supriya Peshin: Meeting Dr. Talal in person after our inspiring conversations was truly incredible
Insight
Dec 15, 2024, 03:39
Petros Grivas: Phenomenal talk by Sumanta K. Pal on RCC